- Home
- TMDX vs TDS Comparison
TMDX vs TDS Comparison
Compare TMDX & TDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- TDS
- Stock Information
- Founded
- TMDX 1998
- TDS 1968
- Country
- TMDX United States
- TDS United States
- Employees
- TMDX N/A
- TDS N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TDS Telecommunications Equipment
- Sector
- TMDX Health Care
- TDS Telecommunications
- Exchange
- TMDX Nasdaq
- TDS Nasdaq
- Market Cap
- TMDX 4.8B
- TDS 4.4B
- IPO Year
- TMDX 2019
- TDS N/A
- Fundamental
- Price
- TMDX $122.68
- TDS $38.89
- Analyst Decision
- TMDX Buy
- TDS Buy
- Analyst Count
- TMDX 9
- TDS 2
- Target Price
- TMDX $123.00
- TDS $52.00
- AVG Volume (30 Days)
- TMDX 1.3M
- TDS 1.5M
- Earning Date
- TMDX 07-30-2025
- TDS 08-11-2025
- Dividend Yield
- TMDX N/A
- TDS 0.41%
- EPS Growth
- TMDX 2163.11
- TDS N/A
- EPS
- TMDX 2.02
- TDS N/A
- Revenue
- TMDX $531,292,000.00
- TDS $4,805,000,000.00
- Revenue This Year
- TMDX $34.57
- TDS N/A
- Revenue Next Year
- TMDX $20.83
- TDS $0.40
- P/E Ratio
- TMDX $61.12
- TDS N/A
- Revenue Growth
- TMDX 48.09
- TDS N/A
- 52 Week Low
- TMDX $55.00
- TDS $20.38
- 52 Week High
- TMDX $177.37
- TDS $42.74
- Technical
- Relative Strength Index (RSI)
- TMDX 51.30
- TDS 53.97
- Support Level
- TMDX $114.30
- TDS $37.44
- Resistance Level
- TMDX $133.54
- TDS $39.19
- Average True Range (ATR)
- TMDX 6.78
- TDS 1.56
- MACD
- TMDX 0.98
- TDS -0.06
- Stochastic Oscillator
- TMDX 51.17
- TDS 54.39
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About TDS Telephone and Data Systems Inc.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.